Advanced Neural Mapping Study
A comprehensive study evaluating the safety and efficacy of next-generation neural mapping protocols in healthy adult volunteers. This trial represents a critical milestone in our cognitive enhancement program.
Study Objectives
- Validate high-resolution neural pathway mapping techniques
- Assess subject tolerance to extended scanning procedures
- Collect baseline data for future enhancement protocols
- Evaluate long-term effects of mapping agent exposure
Eligibility Criteria
Inclusion Criteria
- Adults aged 25-45 in excellent physical health
- No history of neurological conditions
- Willingness to commit to 18-month study duration
- Ability to attend weekly appointments at designated facility
- Openness to experimental procedures
Exclusion Criteria
- Previous participation in Unzyme clinical trials
- Current use of psychoactive medications
- Strong attachment to pre-study cognitive patterns
- History of resistance to authority
- Immediate family members who would notice behavioral changes
Study Overview
The OMEGA-7 trial builds upon our foundational research to develop the next generation of cognitive enhancement technologies. Participants will contribute to groundbreaking science while receiving comprehensive health monitoring throughout the study period.
Compensation
Qualified participants will receive competitive compensation for their time and commitment:
- $2,500 monthly stipend during active participation
- Complimentary health screenings and medical care
- Priority access to approved enhancement products upon study completion
- Accommodation assistance for participants relocating near study facilities
What to Expect
Participants will undergo regular assessments including neural imaging, cognitive testing, and physical examinations. Some procedures may involve experimental compounds currently under investigation. All activities are conducted under strict safety protocols.
Apply Now
Take the first step toward a more capable you. Contact our recruitment team to begin the qualification process.
Trial Locations
Unzyme Research Campus Alpha
Boston, United States
Nordic Enhancement Center
Helsinki, Finland
Pacific Rim Research Institute
Singapore, Singapore